Increasing Adherence to Lung Cancer Screening

Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung cancer screening (LCS) \& diagnostic follow-up across eligible primary care clinicians \& patients. Following the trial, a subsample of patients \& clinicians will be invited to one-time semi-structured interview \& survey to identify individual \& system-level factors that may restrict or enhance the impact of strategies.

NCT Number	NCT05832008
Lead Sponsor	Abramson Cancer Center at Penn Medicine Collaborators: National Comprehensive Cancer Network, AstraZeneca
Conditions	Lung Cancer, Adherence, Patient
Enrollment	825 participants
Start Date	2023-10-18
Primary Completion	2025-08-31 (estimated)
Study Completion	2026-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-07-22